Analysis of mitochondrial ND1 gene in human colorectal cancer

Journal of Research in Medical Sciences

Volumn 16, Issue 1, 2011, Pages 50-55

  Akouchekian, Mansoureh ^a   Houshmand, Massoud ^b   Akbari, Mohammad Hassan Hosseini ^c   Kamalidehghand, Behnam ^d   Dehghane, Masoumeh ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c Baghyatallah University   (Iran)

^d UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^e Special Medical Center Iran   (Iran)

Author keywords

Colorectal Neoplasms; DNA; Electron Transport Complex I; Human; Mitochondrial; MT ND1 Protein; Oxidative Phosphorylation; Reactive Oxygen Species

Indexed keywords

MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL GENETICS; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79551696715     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. McQueen A, Vernon SW, Meissner HI, Klabunde CN, Rakowski W. Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev 2006;15(4):782-91.
2. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, Guzman A, et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 1997;18(5):682-5.
3. Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, et al. Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer 1999;35(2):316-9.
4. Habano W, Sugai T, Nakamura SI, Uesugi N, Yoshida T, Sasou S. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 2000;118(5):835-41.
5. Fernández-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003;88(1):41-56.
6. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun 2003;304(3):519- 29.
7. Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996;98(2):345-51.
8. Lenaz G, Baracca A, Carelli V, D'Aurelio M, Sgarbi G, Solaini G. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochem Biophys Acta 2004;1658(1-2):89-94.
9. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu AL. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 2006;391(3):136-41.
10. Mattiazzi M, Vijayvergiya C, Gajewski CD, DeVivo DC, Lenaz G, Wiedmann M, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004;13(8):869-79.
11. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287(5460):2017-9.
12. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998;20(3):291-3.
13. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281(5381):1309-12.
14. Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD Jr, et al. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 1996;15(2):95-101.
15. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffinembedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 2002;50(8):1005-11.
16. Lee I, Bender E, Arnold S, Kadenbach B. New control of mitochondrial membrane potential and ROS formation--a hypothesis. Biol Chem 2001;382(12):1629-36.
17. Lee I, Bender E, Kadenbach B. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol Cell Biochem 2002;234-235(1-2):63-70.
18. Atlante A, Calissano P, Bobba A, Azzariti A, Marra E, Passarella S. Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. J Biol Chem 2000;275(47):37159-66.
19. Bianchi MS, Bianchi NO, Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 1995;71(1):99-103.
20. Yamamoto H, Tanaka M, Katayama M, Obayashi T, Nimura Y, Ozawa T. Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumor. Biochem Biophys Res Commun 2002;182(2):913-20.
21. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 2001;488(2):119-33.
22. Povalko N, Zakharova E, Rudenskaia G, Akita Y, Hirata K, Toyojiro M, et al. A new sequence variant in mitochondrial DNA associated with high penetrance of Russian Leber hereditary optic neuropathy. Mitochondrion 2005;5(3):194-9.
23. Crispim D, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The European-specific mitochondrial cluster J/T could confer an increased risk of insulin-resistance and type 2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants. Ann Hum Genet 2006;70(Pt 4):488-95.
24. Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation In mitochondrial complex I genes: mutation or polymorphism? J Med Genet 2006;43(2):175-9.
25. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 2005;102(3):719-24.
26. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, et al. Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 2001;92(3):319-21.
27. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001;61(16):5998-6001.
28. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, et al. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 2001;93(4):534-8.
29. Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 2002;62(4):972-6.
30. Durham SE, Krishnan KJ, Betts J, Birch-Machin MA. Mitochondrial DNA damage in non-melanoma skin cancer. Br J Cancer 2003;88(1):90-5.
31. Nomoto S, Sanchez-Cespedes M, Sidransky D. Identification of mtDNA mutations in human cancer. Methods Mol Biol 2002;197:107-17.